Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Ebola Outbreak: CDC on Highest Alert

August 7, 2014 8:58 am | Videos | Comments

The CDC's emergency operations center is watching the outbreak around the clock.                             

TOPICS:

AIDS Patients Fear Discrimination in ACA Exchange

August 7, 2014 8:47 am | by KELLI KENNEDY, Associated Press | News | Comments

Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers. While the issue applies broadly to all patients with chronic illnesses that require expensive medication, HIV and AIDS advocates say they were the first to file a formal complaint with the government about pricing.

TOPICS:

FDA Approves ORBACTIV™ for Acute Bacterial Skin and Skin Structure Infections

August 7, 2014 8:43 am | News | Comments

The Medicines Company today announced that the FDA has approved ORBACTIV™ (oritavancin) for injection for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).

TOPICS:
Advertisement

Mallinckrodt Settles OFIRMEV® Patent Litigation with Fresenius Kabi USA

August 7, 2014 8:40 am | News | Comments

Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, Inc., has entered into settlement and license agreements with Fresenius Kabi USA, LLC, resolving pending patent litigation involving OFIRMEV ® (acetaminophen) injection.

TOPICS:

Takeda President: Company to Extend Global Reach Through Acquisitions

August 7, 2014 8:37 am | News | Comments

New Takeda Pharmaceutical Company President Christophe Weber said recently that Japan's biggest drugmaker will continue efforts to expand its business abroad through acquisitions and will outline a new strategy by the end of the year.   

TOPICS:

How Does Ebola Virus Spread and Can it be Stopped?

August 7, 2014 8:31 am | by MARIA CHENG, AP Medical Writer | News | Comments

As a deadly Ebola outbreak continues in West Africa, health officials are working to calm fears about how the virus spreads, while encouraging those with symptoms to get medical care. Typically, outbreaks of the disease have been in other parts of the continent, not in West Africa.

TOPICS:

Study Ties New Gene to Major Breast Cancer Risk

August 7, 2014 8:29 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

It's long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same.              

TOPICS:

FDA Warns That Tattoo Inks Can Cause Infections

August 7, 2014 8:26 am | by MARY CLARE JALONICK, Associated Press | News | Comments

The Food and Drug Administration is warning tattoo parlors, their customers and those buying at-home tattoo kits that not all tattoo ink is safe. Last month, California company White and Blue Lion Inc. recalled inks in in-home tattoo kits after testing confirmed bacterial contamination in unopened bottles.

TOPICS:
Advertisement

Obama to Sign Veterans' Health Care Overhaul

August 7, 2014 8:22 am | by MATTHEW DALY, Associated Press | News | Comments

Veterans are expected to have an easier time getting government-paid health care from local doctors under a bill that President Barack Obama is set to sign into law Thursday.             

TOPICS:

Mylan Second Quarter Profit Drops 30%

August 7, 2014 7:35 am | by The Associated Press | News | Comments

Mylan reported profit that declined by 30 percent in its second quarter, and missed analysts' expectations. The Canonsburg, Pennsylvania-based company said net income fell to $125.2 million, or 32 cents per share, from $177.7 million, or 46 cents per share.

TOPICS:

Pfizer to Pay $35M to Settle Drug Marketing Case

August 6, 2014 4:38 pm | by The Associated Press | News | Comments

Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses. The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.

TOPICS:

Touch-Screen Computers

August 6, 2014 4:34 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

Introducing the  TP-3010-19AIO and TP-3010-22AIO all-in-one touch-screen, fanless computers with core i3/i5/i7 processors.

TOPICS:

Immersion Circulator

August 6, 2014 4:27 pm | by Nikita Ernst, Associate Editor | Polyscience | Product Releases | Comments

The MX Immersion Circulator enables quality control and R&D charged with testing tablet disintegration time to maintain the testing media at the precise temperature required.

New Evidence Aspirin Prevents Certain Cancers

August 6, 2014 9:03 am | Videos | Comments

New research from London shows taking aspirin can significantly reduce the risk of digestive cancers.                         

TOPICS:

Experimental Drug Used in Treatment of US Ebola Victims

August 6, 2014 9:00 am | Videos | Comments

Health officials are unsure whether the drug is working but friends of the infected are hopeful.                          

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading